SCYNEXIS, Inc. to Focus on SCY-078 Development
July 23, 2015 at 08:35 AM EDT
Drug discovery and development company SCYNEXIS, Inc. (Nasdaq: SCYX) today announced that it has completed an asset purchase agreement ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.